Search - tctmd.com

Displaying 81 - 100 of 144

Sort: Relevancy | Date

News Daily News

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

Todd Neale

September 24, 2015

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

Todd Neale

September 24, 2015

News Daily News

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

August 04, 2015

News Industry News

CorPath® System Robotically Deployed Bioresorbable Vascular Scaffold During Live Broadcast of a Complex Coronary Intervention at 2015 C3 Conference

June 18, 2015

News Conference News ACC 2015

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

L.A. McKeown

March 16, 2015

News Daily News

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

Todd Neale

December 22, 2014

News Daily News

La Revascularización Híbrida para la Enfermedad Multivaso parece Viable y Segura

December 04, 2014

News Daily News

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

L.A. McKeown

November 06, 2014

News Daily News

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

L.A. McKeown

November 06, 2014

News Daily News

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

L.A. McKeown

November 06, 2014

News Daily News

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

August 20, 2014

News Daily News

SYNTAX al cabo de 5 Años: CABG es Más Rentable que la PCI

August 20, 2014

News Daily News

Datos de Registro Confirman un Mayor Riesgo Hemorrágico con la Cirugía No Cardíaca Post-PCI frente a CABG

Caitlin E. Cox

August 20, 2014

Advertisement

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

Study Supports Multiarterial CABG for Multivessel CAD

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

CorPath® System Robotically Deployed Bioresorbable Vascular Scaffold During Live Broadcast of a Complex Coronary Intervention at 2015 C3 Conference

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

La Revascularización Híbrida para la Enfermedad Multivaso parece Viable y Segura

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

SYNTAX al cabo de 5 Años: CABG es Más Rentable que la PCI

Datos de Registro Confirman un Mayor Riesgo Hemorrágico con la Cirugía No Cardíaca Post-PCI frente a CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content